Double-blind, non-inferiority, randomized controlled trial of dexamethasone 4, 5 and 6 mg for preventing adverse neonatal and maternal outcomes in very preterm to late preterm pregnancies between 29 (0) and 36 (6) weeks of gestation: study protocol
Reprod Health. 2025 Mar 3;22(1):30. doi: 10.1186/s12978-025-01965-8. ABSTRACT BACKGROUND: Premature birth poses significant health challenges, including respiratory distress syndrome (RDS). Corticosteroids reduce the incidence of …